Learning Objectives: * Upon completion, participant will be able to better understand the impact of dendritic cell-based immunization strategies o the course of disease in glioblastoma patients. * Upon completion, participant will be able to assess whether patients with glioblastoma live longer if treated with dendritic cell-based immunization strategies.
How are participants able to assess whether patients with GBM live longer when treated with DCVAX if the don't release the detailed trial results???
Scooter- Make sure you cover as this is going to multi dollar it will be costly so don’t know you can afford the chase today and next week. don’t even think/dream trial failure...TLD almost confirmed. Dr. Liau is the presenter in SNO not LP she invented DCVAX and it’s late-breaking abstract.